Rare diseases
Investigational molecules
Locations
Back to Slovakia44 clinical trials in Svidnik, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
SlovakiaStudy of XXB750 and Drug Combination for Patients with Heart Failure
SlovakiaStudy on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension
SlovakiaStudy on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
SlovakiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
SlovakiaStudy on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia
SlovakiaStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
SlovakiaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atherosclerotic cardiovascular disease. Research includes evaluation of new therapeutic combinations and interventions for improving patient outcomes.
Multiple trials investigating novel compounds for reducing major adverse cardiovascular events.
Comprehensive research into chronic skin conditions, particularly hidradenitis suppurativa and chronic spontaneous urticaria. Studies evaluate both established and experimental treatments.
Clinical trials focusing on long-term management and innovative therapeutic approaches.
Studies addressing severe hypertriglyceridemia and related metabolic conditions. Research aims to evaluate new treatments for managing lipid disorders and associated cardiovascular risks.
Innovative approaches to treating complex metabolic disorders with novel therapeutic agents.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
